Results 171 to 180 of about 1,412,582 (334)
Natural products from plants and microorganisms: Novel therapeutics for chronic kidney disease via gut microbiota regulation [PDF]
, 2023 Zheng Lin +3 more
openalex +1 more source
Survivin and Aurora Kinase A control cell fate decisions during mitosis
Molecular Oncology, EarlyView.Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir +2 more
wiley +1 more source
Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics [PDF]
Yuxiao Jiang +5 more
openalex +1 more source
Editorial: Inflammation in Cardiovascular Diseases: Role of the Endothelium and Emerging Therapeutics [PDF]
, 2020 Cheng Xue Qin +2 more
openalex +1 more source
Molecular Oncology, EarlyView.CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir +12 more
wiley +1 more source
Molecular Oncology, EarlyView.A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
Shell crosslinked nanoparticles carrying silver antimicrobials as therapeutics
, 2009 Yali Li +9 more
openalex +2 more sources
Mass Spectrometry Approaches Empowering Neuropeptide Discovery and Therapeutics [PDF]
, 2022 Krishna D. B. Anapindi +3 more
openalex +1 more source